全文获取类型
收费全文 | 31435篇 |
免费 | 4125篇 |
国内免费 | 940篇 |
专业分类
耳鼻咽喉 | 535篇 |
儿科学 | 522篇 |
妇产科学 | 440篇 |
基础医学 | 6110篇 |
口腔科学 | 1140篇 |
临床医学 | 2949篇 |
内科学 | 4971篇 |
皮肤病学 | 511篇 |
神经病学 | 1925篇 |
特种医学 | 725篇 |
外国民族医学 | 17篇 |
外科学 | 3119篇 |
综合类 | 3905篇 |
现状与发展 | 7篇 |
预防医学 | 1303篇 |
眼科学 | 852篇 |
药学 | 3508篇 |
17篇 | |
中国医学 | 1283篇 |
肿瘤学 | 2661篇 |
出版年
2024年 | 88篇 |
2023年 | 724篇 |
2022年 | 780篇 |
2021年 | 1854篇 |
2020年 | 1653篇 |
2019年 | 1585篇 |
2018年 | 1459篇 |
2017年 | 1561篇 |
2016年 | 1687篇 |
2015年 | 1706篇 |
2014年 | 2131篇 |
2013年 | 3133篇 |
2012年 | 1673篇 |
2011年 | 1819篇 |
2010年 | 1495篇 |
2009年 | 1373篇 |
2008年 | 1403篇 |
2007年 | 1375篇 |
2006年 | 1248篇 |
2005年 | 1020篇 |
2004年 | 933篇 |
2003年 | 742篇 |
2002年 | 652篇 |
2001年 | 542篇 |
2000年 | 453篇 |
1999年 | 405篇 |
1998年 | 370篇 |
1997年 | 278篇 |
1996年 | 284篇 |
1995年 | 255篇 |
1994年 | 200篇 |
1993年 | 214篇 |
1992年 | 157篇 |
1991年 | 141篇 |
1990年 | 106篇 |
1989年 | 101篇 |
1988年 | 99篇 |
1987年 | 81篇 |
1986年 | 92篇 |
1985年 | 101篇 |
1984年 | 82篇 |
1983年 | 51篇 |
1982年 | 62篇 |
1981年 | 76篇 |
1980年 | 55篇 |
1979年 | 38篇 |
1978年 | 37篇 |
1977年 | 42篇 |
1976年 | 21篇 |
1975年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 16 毫秒
1.
2.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
3.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
4.
5.
6.
7.
目的 探讨肿瘤位置、最大直径及甲状腺外浸等临床病理特征与甲状腺癌前上纵隔淋巴结转移的关系。 方法 研究分析初次手术治疗的60例甲状腺乳头状癌患者临床及病理资料,运用检验临床病理特征与前上纵隔淋巴结阳性率的相关性。 结果 肿块位置、最大直径、数量、腺体外侵、受累腺叶数及Ⅵ区淋巴结转移等特征,以及患者年龄等相关因素中,只有VI区淋巴结对前上纵隔淋巴结状态有影响;60例患者前上纵隔淋巴结转移率为10/60(16.67%)。相关因素的前上纵隔淋巴结转移率对比:≥55岁vs <55岁(20% vs 16.36%, P<0.05);肿块位于下极 vs 上极 vs 中极(P>0.05);最大直径≥1.5 cm vs 最大直径<1.5 cm(18.18% vs 15.79, P>0.05);单灶 vs 多灶(21.88% vs 10.71%, P>0.05);单叶 vs 多叶(17.5% vs 15%, P>0.05);男性vs女性(20% vs 15.55%, P>0.05); Ⅵ区淋巴结阳性vs 阴性(24.43% vs 3.57%, P<0.05); 结论 总体来说,甲状腺乳头状癌前上纵隔淋巴结转移率较低。本研究发现VI区淋巴结状态可能与前上纵隔淋巴结转移相关,未来仍需大样本前瞻性的研究验证。 相似文献
8.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
9.
10.
BackgroundTumor mutation burden (TMB) as a prognostic marker for immunotherapy has shown prognostic value in many cancers. However, there is no systematic investigation on TMB in papillary thyroid carcinoma (PTC).MethodsBased on the somatic mutation data of 487 PTC patients from The Cancer Genome Atlas (TCGA), TMB was calculated, and we classified the samples into high-TMB (H-TMB) and low-TMB (L-TMB) groups. Bioinformatics methods were used to explore the characteristics and potential mechanism of TMB in PTC.ResultsHigh TMB predicts shorter progression-free survival (PFS) (P < 0.001). TMB was positively correlated with age, stage, tumor size, metastasis, the male sex and tall cell PTC. Compared to the L-TMB group, the H-TMB group presented with lower immune cell infiltration, a higher proportion of tumor-promoting immune cells (M0 macrophages, activated dendritic cells and monocytes) and a lower proportion of antitumor immune cells (M1 macrophages, CD8+ T cells and B cells). Additionally, the characteristics displayed by different TMB groups were not driven by critical driver mutations such as BRAF and RAS.ConclusionsPTC patients with high TMB have a worse prognosis. By stratifying PTC patients according to their TMB, advanced PTC patients who are candidates for immunotherapy could be selected. 相似文献